The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Open accessAbstract
The RASSF1A locus at 3p21.3 is epigenetically inactivated at high frequency in a variety of solid tumors. Expression of RASSF1A is sufficient to revert the tumorigenicity of human cancer cell lines. We show here that RASSF1A can induce cell cycle arrest by engaging the Rb family cell cycle checkpoint. RASSF1A inhibits accumulation of native cyclin D1, and the RASSF1A-induced cell cycle arrest can be relieved by ectopic expression of cyclin D1 or of other downstream activators of the G(1)/S-phase transition (cyclin A and E7). Regulation of cyclin D1 is responsive to native RASSF1A activity, because RNA interference-mediated downregulation of endogenous RASSF1A expression in human epithelial cells results in abnormal accumulation of cyclin D1 protein. Inhibition of cyclin D1 by RASSF1A occurs posttranscriptionally and is likely at the level of translational control. Rare alleles of RASSF1A, isolated from tumor cell lines, encode proteins that fail to block cyclin D1 accumulation and cell cycle progression. These results strongly suggest that RASSF1A is an important human tumor suppressor protein acting at the level of G(1)/S-phase cell cycle progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Accumulation of cyclin D1 protein during G1 contributes to bypass of Rb family restriction point control (32).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“Many mitogenic and oncogenic signal transduction cascades converge at the level of cyclin D1 accumulation, enhancing promoter activation (3, 18, 23), mRNA stability (11, 25), translation (28), and/or protein stability (1, 8).”
BackgroundWeinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Cyclin A is required at two points in the human cell cycle.
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., & Draetta, G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05135.x · Cited by 1,403
SMART: a web-based tool for the study of genetically mobile domains
Schultz, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.231 · Cited by 1,378
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Self-citationFrisch, S. M., & Ruoslahti, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80124-x · Cited by 1,151
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Self-citationEpigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Self-citationDiehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 1×
“dependent polyubiquitination and degradation by the 26S proteosome (9).”
BackgroundMice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Multiple ras functions can contribute to mammalian cell transformation
White, M. A., Nicolette, C., Minden, A., Polverino, A., Aelst, L. V., Karin, M., & Wigler, M. H. (1995) · Cell · doi:10.1016/0092-8674(95)90507-3 · Cited by 649
Self-citationLerman, M. I., & Minna, J. D. (2000) · PubMed · Cited by 538
Self-citationMuise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511
Specific Chromosome Defect Associated with Human Small-Cell Lung Cancer: Deletion 3p(14-23)
Whang-Peng, J., Kao-Shan, C. S., Lee, E. C., Bunn, P. A., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1982) · Science · doi:10.1126/science.6274023 · Cited by 452
Self-citationWistuba, I. I., Behrens, C., Virmani, A. K., Mele, G. M., Milchgrub, S., Girard, L., Fondon, J. W., Garner, H. R., McKay, B., Latif, F., et al. (2000) · PubMed · Cited by 405
Self-citationAgami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
Goodwin, E. C., & DiMaio, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12513 · Cited by 362
Assoian, R. K., & Schwartz, M. A. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00155-6 · Cited by 341
Hung, J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310056030 · Cited by 339
Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60096-2 · Cited by 335
Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
Self-citationHigh frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S. Y., Chow, L. S. N., Teo, P., Johnson, P. J., & Huang, D. P. (2001) · PubMed · Cited by 290
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis
Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., & Clark, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000463200 · Cited by 289
Dammann, R., Yang, G., & Pfeifer, G. P. (2001) · PubMed · Cited by 280
Lee, R. J., Albanese, C., Stenger, R. J., Watanabe, G., Inghirami, G., Haines, G. K., Webster, M., Muller, W. J., Brugge, J. S., Davis, R. J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7341 · Cited by 226
Self-citationIdentification of Nore1 as a Potential Ras Effector
Vavvas, D., Li, X., Avruch, J., & Zhang, X.-F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5439 · Cited by 208
Albanese, C., D'Amico, M., Reutens, A. T., Fu, M., Watanabe, G., Lee, R. J., Kitsis, R. N., Henglein, B., Avantaggiati, M., Somasundaram, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34186 · Cited by 190
Self-citationMaitra, A., Wistuba, I. I., Washington, C., Virmani, A. K., Ashfaq, R., Milchgrub, S., Gazdar, A. F., & Minna, J. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61679-3 · Cited by 148
Self-citationLin, S., Wang, W., Wilson, G. M., Yang, X., Brewer, G., Holbrook, N. J., & Gorospe, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.7903-7913.2000 · Cited by 140
Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κB
Henry, D. O., Moskalenko, S. A., Kaur, K. J., Fu, M., Pestell, R. G., Camonis, J., & White, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.21.8084-8092.2000 · Cited by 126
Self-citationDufourny, B., van Teeffelen, H. A. A. M., Hamelers, I. H. L., Sussenbach, J. S., & Steenbergh, P. H. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660329 · Cited by 61
Cited by
Donninger, H., Vos, M. D., & Clark, G. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 440
Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
Zabarovsky, E. R., Lerman, M. I., & Minna, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205835 · Cited by 382
Self-citationDNA methylation profiles in cancer diagnosis and therapeutics
Pan, Y., Liu, G., Zhou, F., Su, B., & Li, Y. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0467-0 · Cited by 373
Cdc20: A WD40 Activator for a Cell Cycle Degradation Machine
Yu, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.009 · Cited by 354
Metadata
- Authors
- Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-06-01
- Volume
- 22
- Issue
- 12
- Pages
- 4309-4318
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2158150128
- Cited by
- 393
- References
- 39
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.